SWA1211
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SWA1211, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors [Phase 1]